Before mass production injection molding begins, mold quality directly determines product yield, cycle stability, and enormous production costs! A single defective mold can lead to millions of scrap parts, frequent downtime for repairs, and immeasurable losses. We offer comprehensive injection mold quality validation services to safeguard the final step before full-scale production, ensuring “first-shot success and stable mass production.”
Core validation process includes:
- 100% Mold Structure & Dimensional Inspection: Using high-precision Coordinate Measuring Machines (CMM) and vision measuring systems, we fully inspect parting lines, slides, ejection systems, cooling channels, and other critical dimensions, maintaining tolerances within ±0.005 mm to prevent assembly interference and flash.
- Mold Flow Analysis + Actual Trial Molding Verification: Professional CAE mold flow analysis predicts filling, packing, warpage, and sink mark risks; followed by multiple trial shots (T0/T1/T2 stages) to validate real flow, venting, and cooling performance, while optimizing injection parameters for a robust process window.
- Mold Movement & Durability Testing: Fully automated cycling tests for mold open/close, slide core pulling, and lifter actions ≥5,000 times to confirm smooth operation without sticking, jamming, or abnormal noise; simultaneously verify hot runner / heating system temperature control stability under simulated long-term load.
- Surface & Hardness Inspection: Comprehensive evaluation of cavity mirror polish, chrome/nitriding layer thickness, and core/cavity hardness (HRC) to prevent early galling, chipping, and extend mold lifespan.
- Full Sample Quality Assessment: Inspect trial parts for dimensions, weight, appearance, strength, shrinkage, etc., and issue detailed reports aligned with customer tolerance requirements, including First Article Inspection (FAI) and PPAP documentation support.
Through this pre-production mold validation, we have helped hundreds of automotive, medical, and consumer electronics clients achieve first-trial pass rates above 95%, mass production scrap rates below 0.5%, and significantly reduce trial costs and ramp-up risks!